How the GH and androgen axes interact, and what the evidence does and does not show
Sermorelin is a GHRH analogue whose US approval (for children with growth hormone deficiency) was withdrawn in 2008; research-grade sermorelin is sold for laboratory use only. Testosterone is a prescription medicine. People ask how the two interact because they act on different hormonal axes. This page covers what is known about that interaction and what is not. It does not cover how to use either: testosterone therapy, and anything combined with it, is a decision for a prescribing physician.
The two axes do interact. In physiology studies, testosterone raises the amplitude of natural GH pulses, and men with low testosterone tend to have smaller GH pulses. GH in turn drives IGF-1. Whether adding sermorelin to testosterone therapy changes any health outcome has not been tested in a controlled trial.
Studies that gave growth hormone itself together with testosterone to older men found larger changes in lean mass and fat than either alone, along with more side effects such as fluid retention and joint pain. Those trials used GH, not sermorelin, under medical supervision. No trial has tested sermorelin with testosterone, so the "synergy" claimed online is extrapolated, not measured.
No. The "standard protocols" circulating online, with testosterone and sermorelin amounts and timings, come from clinics marketing combinations and from forums, not from trials. Compound Review does not publish dosing protocols for any compound, and testosterone dosing is set by a prescriber.
Exogenous testosterone suppresses the HPG axis (LH/FSH), reducing endogenous testosterone production. Sermorelin does not suppress the HPG axis — it stimulates the GH axis independently. Sermorelin also does not affect LH or FSH.
The combination has not been studied for safety. Testosterone therapy has its own monitored risks (raised haematocrit, changes in lipids, effects on fertility), and raising GH and IGF-1 brings others (fluid retention, joint pain, effects on blood sugar). Research-grade sermorelin is made without pharmaceutical oversight. Sermorelin is sold for laboratory research only and is not for human or animal consumption.
That is a question for a prescribing physician. Testosterone is a prescription medicine, sermorelin is no longer an approved drug in the US, and no trial has tested the two together. Compound Review does not give guidance on using either.
Possibly in principle: testosterone raises natural GH pulse amplitude, and men with low testosterone tend to have smaller GH pulses. Whether that changes anything sermorelin does has not been measured.
Sermorelin acts on the GHRH receptor and the GH/IGF-1 axis; it is not known to act on the hormones (LH and FSH) that control testosterone production. There are no trials measuring testosterone during sermorelin use.
No research identifies one. Combinations of TRT with sermorelin or ipamorelin are marketed by some clinics but have not been tested in controlled trials. We do not publish combination or dosing protocols.
Research Use Only
All content is for educational and research purposes. Not medical advice. Always consult a qualified healthcare professional before combining any compounds.
Research Grade
Shop Purgo Labs
Use Code HEALTH for 30% Off